Alternating Romosozumab with Alendromate to Reduces Risk of Fractures
Treatment for osteoporosis with romosozumab and alendronate was effective in improving bone density and reducing the risk of fracture in postmenopausal women. The new treatment for osteoporosis is more effective against fractures than the current standard treatment.